Cutler Group LP Ginkgo Bioworks Holdings, Inc. Transaction History

Cutler Group LP

$307 Million
Q1 2024

A detailed history of Cutler Group LP transactions in Ginkgo Bioworks Holdings, Inc. stock. As of the latest transaction made, Cutler Group LP holds 7,700 shares of DNA stock, worth $2,618. This represents 0.0% of its overall portfolio holdings.

Number of Shares

7,700

Previous 7,929 2.89%

Holding current value

$2,618

Previous $13,000 38.46%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 19, 2024	SELL	$1.06 - $1.67 $242 - $382	-229 Reduced 2.89%	7,700 $8,000
Q4 2023 Jan 18, 2024	SELL	$1.26 - $1.79 $4,788 - $6,802	-3,800 Reduced 32.4%	7,929 $13,000
Q3 2023 Nov 07, 2023	BUY	$1.61 - $2.54 $930 - $1,468	578 Added 5.18%	11,729 $21,000
Q2 2023 Jul 18, 2023	SELL	$1.14 - $1.95 $4,296 - $7,349	-3,769 Reduced 25.26%	11,151 $20,000
Q1 2023 May 01, 2023	BUY	$1.2 - $2.19 $1,617 - $2,952	1,348 Added 9.93%	14,920 $19,000

Q4 2022 Feb 07, 2023	BUY	$1.63 - $3.52 $9,571 - $20,669	5,872 Added 76.26%	13,572 $22,000
Q3 2022 Oct 25, 2022	SELL	$0.73 - $3.74 $11,616 - $59,514	-15,913 Reduced 67.39%	7,700 $24,000
Q2 2022 Aug 04, 2022	BUY	$2.2 - $4.2 $5,405 - $10,319	2,457 Added 11.61%	23,613 $56,000
Q1 2022 Apr 14, 2022	SELL	$2.83 - $8.69 $13,949 - $42,833	-4,929 Reduced 18.9%	21,156 $85,000
Q4 2021 Jan 18, 2022	BUY	$8.31 - $14.92 $49,261 - $88,445	5,928 Added 29.41%	26,085 $216,000
Q3 2021 Oct 26, 2021	BUY	$9.15 - $13.28 $184,436 - $267,684	20,157 New	20,157 $233,000

Others Institutions Holding DNA

# of Institutions

359

Shares Held

1.26B

Call Options Held

845K

Put Options Held

2.54M

View Full List

About Ginkgo Bioworks Holdings, Inc.

Ticker DNA
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,287,779,968
Market Cap $438M
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...

More about DNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.

Account